Beauty Farm Medical and Health Industry Inc. conducted an on-market buyback of 44,000 ordinary shares on 23 June 2026. The transaction was executed on the Hong Kong Stock Exchange at prices ranging from HK$16.83 to HK$17.03, for a volume-weighted average of HK$16.92 per share. The aggregate consideration reached HK$0.74 million.
Following the repurchase, Beauty Farm’s issued share capital (excluding treasury shares) decreased by 0.0177% to 248.59 million shares, while treasury shares rose to 3.00 million. Total issued shares, including treasury stock, remain unchanged at 251.59 million.
The buyback forms part of the company’s mandate, approved on 27 June 2025, which authorises the repurchase of up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 3.00 million shares, representing 1.27% of the shares outstanding on the mandate date (235.80 million).
Pursuant to Hong Kong listing rules, Beauty Farm is subject to a 30-day moratorium on new share issues or treasury share disposals, lasting until 23 July 2026.
Comments